Location History:
- Chester Springs, PA (US) (2018)
- Meridian, ID (US) (2021)
Company Filing History:
Years Active: 2018-2021
Title: Mark L Lupher, Jr: Innovator in Fibrotic Cancer Treatment
Introduction
Mark L Lupher, Jr. is a notable inventor based in Chester Springs, PA (US). He has made significant contributions to the field of medical research, particularly in the treatment of fibrotic cancers. With a total of 2 patents, his work focuses on innovative methods that aim to improve patient outcomes.
Latest Patents
Lupher's latest patents include groundbreaking methods for treating fibrotic cancers. One patent details methods of treating fibrotic cancers by administering Serum Amyloid Protein (SAP) agonists. This method may also involve the conjoint administration of anti-cancer therapeutics, such as chemotherapeutic agents. Another patent outlines methods for treating fibrosis using C-reactive protein (CRP) antagonists. This application provides methods for assessing a patient's risk of developing fibrosis or related disorders by measuring concentrations of CRP and SAP from biological samples. The SAP-to-CRP ratio is then compared to reference ratios to determine risk levels. These diagnostic methods can also assess the severity of fibrosis in affected patients.
Career Highlights
Mark L Lupher, Jr. is currently associated with Promedior, Inc., where he continues to advance his research in fibrotic diseases. His innovative approaches have the potential to transform treatment protocols and improve the quality of life for patients suffering from these conditions.
Collaborations
Lupher collaborates with talented professionals in his field, including Teresa K Surowy and Shawn Li. Their combined expertise contributes to the development of effective therapeutic strategies.
Conclusion
Mark L Lupher, Jr. stands out as an influential inventor in the realm of fibrotic cancer treatment. His patents reflect a commitment to advancing medical science and improving patient care.